Soleus Capital

Portfolio Co Investors 2026 for Soleus Capital: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.

Soleus Capital accounts for 13 tracked companies with verified cap-table data, 13 of which disclose round sizes totalling $1.6B. The median disclosed raise is $95M, and the largest is Genapsys Inc. at $250M, ahead of Abcuro ($200M) and Artios Pharma ($186M).

The names that recur most often on these co-invested cap tables are Soleus Capital (13 companies), Foresite Capital (2 companies), Farallon Capital Management, L.L.C. (2 companies), RA Capital Management (2 companies), BlackRock (2 companies), Avidity Partners (2 companies). By latest disclosed round, the market skews Series C (5), Series D (4), Series B (3).

Best funded Soleus Capital companies

  1. Genapsys Inc. — $250M (latest: Series D)
  2. Abcuro — $200M (latest: Series C)
  3. Artios Pharma — $186M (latest: Series C)
  4. Celcuity — $175M (latest: Series B)
  5. INBRACE — $127M (latest: Series D)
  6. Neurona Therapeutics — $126M (latest: Series B)
  7. Field Trip Health — $95M
  8. Mission Bio — $94M (latest: Series C)
  9. TwinStrand Biosciences — $78M (latest: Series B)
  10. BioAtla — $73M (latest: Series D)
  11. Pillar Biosciences — $64M (latest: Series C)
  12. Q'Apel Medical — $52M (latest: Series D)
  13. Parse Biosciences — $50M (latest: Series C)

Soleus Capital — related firms and companies (55)

Soleus Capital profile · All research reports